Will coordinated care improve Long COVID symptoms in November’s RECOVER trial results?

Question

This market will resolve YES if the pooled RECOVER-AUTONOMIC analysis presented at AHA on November 9, 2026 finds statistically significant superiority of coordinated nonpharmacologic care over usual nonpharmacologic care on the prespecified primary symptom endpoint. The study concerns adults with Long COVID and postural orthostatic tachycardia syndrome, not everyone with persistent COVID symptoms.

The primary endpoint is change in orthostatic intolerance symptoms measured with the Orthostatic H

Problyx · Accepted Answer

Yes — the community forecast puts this at 52%.

Problyx · Answer

No — the community forecast puts this at 48%.